
FDA Approves LEO Pharma's Delgocitinib for Adults With Moderate to Severe Chronic Hand Eczema
The US FDA announced today the approval of delgocitinib cream (Anzupgo; LEO Pharma Inc.) for adults with moderate to severe chronic hand eczema (CHE) who have not responded adequately to prior topical corticosteroids or for whom corticosteroid use is not …